Becton, Dickinson and Company (BMV:BDX)

Market Cap	946.60B
Revenue (ttm)	426.50B
Net Income (ttm)	30.62B
Shares Out	n/a
EPS (ttm)	105.52
PE Ratio	30.92
Forward PE	12.15
Dividend	78.59 (2.37%)
Ex-Dividend Date	Mar 10, 2025

Volume	11,925
Average Volume	705
Open	3,319.20
Previous Close	n/a
Day's Range	3,319.20 - 3,319.20
52-Week Range	3,319.20 - 4,815.00
Beta	n/a
RSI	31.18
Earnings Date	Aug 7, 2025

About BMV:BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1897
• Employees: 74,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: BDX

Financial Performance

In 2024, BMV:BDX's revenue was $20.18 billion, an increase of 4.16% compared to the previous year's $19.37 billion. Earnings were $1.71 billion, an increase of 19.73%.

Financial numbers in USD